Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.750
+0.140 (3.04%)
Oct 6, 2026, 5:37 PM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.48 billion as of October 6, 2026. Its market cap has increased by 8.76% in one year.
Market Cap
1.48B
Enterprise Value
1.79B
Revenue
711.06M
Ranking
n/a
PE Ratio
17.71
Stock Price
€4.75
ChartMarket Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.48B, an increase of 804.32%. That is a compound annual growth rate of 6.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 1.48B | -7.89% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 2.94B |
| Almirall | 2.23B |
| Pharma Mar | 1.24B |
| Clínica Baviera | 891.44M |
| Oryzon Genomics | 223.92M |
| Laboratorio Reig Jofre | 215.04M |
| Prim, S.A. | 214.30M |